Literature DB >> 23875973

Protective reactivity and alteration of the brain tissue in alcoholics evidenced by SOD1, MMP9 immunohistochemistry, and electron microscopy.

Sandra Skuja1, Valerija Groma, Kristine Ravina, Mihails Tarasovs, Vinita Cauce, Ojars Teteris.   

Abstract

Alcohol and its associated oxidative stress is one of the widespread contributors to the brain damage. Matrix metalloproteinases, which are extensively analyzed in brain pathology studies, are not sufficiently investigated in chronic alcohol consumption. This study evaluated regional brain damage caused by oxidative stress. Contribution of metalloproteinase-9 to this affection was evidenced in alcoholic subjects and correlated with ultrastructural changes. The authors found correlation between neuronal expression patterns of superoxide dismutase-1 and metalloproteinase-9 in nigral (r = 0.532, p < 0.001), striatal (r = 0.327, p < 0.001), and cortical (r = 0.306, p < 0.001) regions, and a significant decrease of nigral superoxide dismutase-1 median values accompanied by severe myelin damage.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23875973     DOI: 10.3109/01913123.2013.810688

Source DB:  PubMed          Journal:  Ultrastruct Pathol        ISSN: 0191-3123            Impact factor:   1.094


  3 in total

Review 1.  Function and Mechanism of Myelin Regulation in Alcohol Abuse and Alcoholism.

Authors:  James Rice; Chen Gu
Journal:  Bioessays       Date:  2019-05-16       Impact factor: 4.345

2.  Bexarotene normalizes chemotherapy-induced myelin decompaction and reverses cognitive and sensorimotor deficits in mice.

Authors:  Angie C A Chiang; Alexandre V Seua; Pooja Singhmar; Luis D Arroyo; Rajasekaran Mahalingam; Jian Hu; Annemieke Kavelaars; Cobi J Heijnen
Journal:  Acta Neuropathol Commun       Date:  2020-11-12       Impact factor: 7.801

3.  Morphopathological approaches in alcoholism.

Authors:  Ana Miruna Drăgoi; Tiana Voicu; Ana Maria Chipeşiu; Radu Virgil Costea
Journal:  Rom J Morphol Embryol       Date:  2020 Apr-Jun       Impact factor: 1.033

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.